Conclusions A GPx3 increase in response to selenium treatment was observed in patients with GFR below 90 ml/min/1.73 m 2 , selenium below 70 g/l and GPx3 activity below 250 U/l at baseline
dose-for-dose comparison is not one-to-one Dosing reliability depends on patient technique (adequate spray volume, appropriate positioning, holding time in the mouth before swallowing) Some interindividual variability in absorption Licensed Healthcare Practitioners 1,000+ physician-grade products, bulk-tier pricing, and direct shipping to your practice
Future trials should examine both induction and maintenance therapy applications, biomarker responses, and endoscopic healing outcomes to establish clinical utility
Manufacturers therefore compete on evidence generation as much as commercial execution
Beste MT, Pfffle-Doyle N, Prentice EA, Morris SN, Lauffenburger DA, Isaacson KB, et al